A non‐invasive measure of bone growth in mammals: Validating urinary CTX‐I as a bone resorption marker through long‐bone growth velocity in bonobos.

Assessing bone growth trajectories in mammals is crucial for understanding life history dynamics, but the quantification of bone growth in natural settings can be challenging. Bone resorption markers that can be measured in urine, such as C‐telopeptide of type I collagen (CTX‐I), offer a non‐invasive solution to assess bone growth. Although measurement of urinary CTX‐I levels has been applied extensively in human studies, its use in other species is so far limited to a few clinical studies. To validate urinary CTX‐I as a bone resorption marker under less controlled conditions, we investigated within‐individual day‐to‐day variation, diurnal patterns, and sex and age‐specific variation in zoo‐housed bonobos (Pan paniscus). We then also correlated urinary CTX‐I levels with forearm growth velocity measures. We found a day‐to‐day variability in urinary CTX‐I levels of around 25%, comparable to human variation. Diurnally, CTX‐I levels decreased, aligning with observations in humans and other species. Both sexes showed an age‐related decline in urinary CTX‐I levels, with a steady decrease after the age of 10 years. Additionally, we found a positive correlation between forearm growth velocity and urinary CTX‐I levels across age in female, but not in male, bonobos. Our results demonstrate that urinary CTX‐I levels are a meaningful measure of bone growth and highlight its potential to examine bone growth trajectories also in wild populations to investigate life history dynamics. [ABSTRACT FROM AUTHOR]